Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.66
-0.57 (-2.56%)
At close: Apr 28, 2026, 4:00 PM EDT
21.66
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
KMTS Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
| Jan '26 Jan 31, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Revenue | 83.72 | 59.82 | 27.81 | 7.63 | - | - |
| Revenue Growth (YoY) | 59.06% | 115.05% | 264.54% | - | - | - |
| Cost of Revenue | 42.91 | 35.61 | 27.45 | 18.28 | - | - |
| Gross Profit | 40.81 | 24.21 | 0.36 | -10.65 | - | - |
| Selling, General & Admin | 165.19 | 114.94 | 69.94 | 54.01 | 13.9 | 6.52 |
| Research & Development | 19.24 | 15.65 | 15.49 | 15.76 | 18.81 | 22.8 |
| Operating Expenses | 184.42 | 130.59 | 85.43 | 69.77 | 32.71 | 29.32 |
| Operating Income | -143.61 | -106.38 | -85.06 | -80.42 | -32.71 | -29.32 |
| Interest Expense | -7.46 | -7.73 | -6.23 | -5.63 | -1.17 | - |
| Interest & Investment Income | 7.78 | 3.2 | - | - | - | - |
| Other Non Operating Income (Expenses) | -0.39 | -2.77 | -0.09 | 1.83 | -0.04 | - |
| EBT Excluding Unusual Items | -143.68 | -113.68 | -91.38 | -84.22 | -33.91 | -29.32 |
| Other Unusual Items | - | - | -2.72 | - | - | - |
| Pretax Income | -143.68 | -113.68 | -94.1 | -84.22 | -33.91 | -29.32 |
| Income Tax Expense | 0.2 | 0.14 | 0.02 | 0.02 | 0.19 | 0.15 |
| Net Income | -144.83 | -113.81 | -94.12 | -84.24 | -34.1 | -29.47 |
| Preferred Dividends & Other Adjustments | 3.29 | 12.32 | 6.72 | 2.5 | - | - |
| Net Income to Common | -148.12 | -126.14 | -100.84 | -86.74 | -34.1 | -29.47 |
| Shares Outstanding (Basic) | 49 | 25 | 20 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 49 | 25 | 20 | 0 | 0 | 0 |
| Shares Change (YoY) | 147.93% | 23.63% | 18693.84% | - | - | - |
| EPS (Basic) | -3.00 | -5.13 | -5.07 | -819.76 | -322.29 | -278.50 |
| EPS (Diluted) | -3.00 | -5.13 | -5.07 | -819.76 | -322.29 | -278.50 |
| Free Cash Flow | -120.21 | -101.2 | -84.75 | -85.1 | -30.23 | -30.53 |
| Free Cash Flow Per Share | -2.44 | -4.12 | -4.26 | -804.32 | -285.72 | -288.49 |
| Gross Margin | 48.75% | 40.48% | 1.30% | -139.59% | - | - |
| Operating Margin | -171.53% | -177.84% | -305.83% | -1054.01% | - | - |
| Profit Margin | -176.92% | -210.88% | -362.56% | -1136.79% | - | - |
| Free Cash Flow Margin | -143.59% | -169.19% | -304.70% | -1115.37% | - | - |
| EBITDA | -135.39 | -98.41 | -73.5 | -75.57 | -32.29 | -28.84 |
| EBITDA Margin | -161.71% | -164.52% | -264.27% | - | - | - |
| D&A For EBITDA | 8.22 | 7.97 | 11.56 | 4.86 | 0.42 | 0.48 |
| EBIT | -143.61 | -106.38 | -85.06 | -80.42 | -32.71 | -29.32 |
| EBIT Margin | -171.53% | -177.84% | - | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.